Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) |
| BNF code | 0408010W0BKABA1 |
| Virtual Medicinal Product | Sodium valproate 300mg modified-release tablets |
| Name | Dyzantil 300mg modified-release tablets |
| Supplier | Aspire Pharma Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.